Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction

AB Addison, B Wong, T Ahmed, A Macchi… - Journal of Allergy and …, 2021 - Elsevier
Background Respiratory tract viruses are the second most common cause of olfactory
dysfunction. As we learn more about the effects of severe acute respiratory syndrome …

The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review

S Oliaei, SA SeyedAlinaghi, M Mehrtak… - European journal of …, 2021 - Springer
Background Oxygenation serves as a cornerstone in the treatment of COVID-19, and several
methods have been extensively studied so far. Herein, we aimed to systematically review …

[HTML][HTML] Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage

N Kirtipal, S Kumar, SK Dubey, VD Dwivedi… - Infection, Genetics and …, 2022 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), accountable for causing
the coronavirus diseases 2019 (COVID-19), is already declared as a pandemic disease …

Purinergic signaling elements are correlated with coagulation players in peripheral blood and leukocyte samples from COVID-19 patients

IC Schultz, APS Bertoni, MR Wink - Journal of Molecular Medicine, 2022 - Springer
For over a year, the coronavirus disease 2019 has been affecting the world population by
causing severe tissue injuries and death in infected people. Adenosine triphosphate (ATP) …

A automedicação no período de pandemia de COVID-19: Revisão integrativa

JVL Oliveira, FB da Costa… - Research, Society and …, 2021 - rsdjournal.org
Abstract Sars-CoV-2, Coronavirus or COVID-19, is a viral spectrum respiratory syndrome
first evidenced in December 2019 in Wuhan, China. Because it is still a little known virus …

Comparative efficacy and safety of pharmacological interventions for severe COVID-19 patients: An updated network meta-analysis of 48 randomized controlled trials

Q Cheng, G Zhao, J Chen, Q Jia, Z Fang - Medicine, 2022 - journals.lww.com
Background: To date, there has been little agreement on what drug is the" best" drug for
treating severe COVID-19 patients. This study aimed to assess the efficacy and safety of …

Effectiveness of Hyperbaric Oxygen Therapy in SARS-CoV-2 Pneumonia: The Primary Results of a Randomised Clinical Trial

J Siewiera, K Brodaczewska, N Jermakow… - Journal of Clinical …, 2022 - mdpi.com
Mortality in COVID-19 is mainly associated with respiratory failure, cytokine storm, and
macrophage activation. Oxygenation and anti-inflammatory effects of Hyperbaric Oxygen …

[PDF][PDF] Hyperbaric oxygen therapy as a supportive therapy for COVID-19 patients: a narrative review.

NM Allam, HM Eladl, MM Eid - European Review for Medical & …, 2022 - europeanreview.org
The Coronavirus illness 2019 (COVID-19) was first observed to induce fever, dry cough,
pneumonia, and dyspnea in the lower respiratory tract. Atypical manifestations, including …

[PDF][PDF] Пандемия COVID-19: актуальные вызовы времени, а также новейшие данные к вопросу рационального выбора психофармакотерапии у пациентов с …

НН Петрова, ПВ Морозов, АВ Маркин… - Психиатрия и …, 2020 - academia.edu
Резюме Бушующая в последний год во всем мире пандемия COVID-19 привела к
резкому ухудшению психического здоровья и психологического благополучия всей …

[PDF][PDF] Recovery of post COVID-19 survivors with the methods of sanatorial and SPA treatment

M Petrova, K Takucheva, K Mollova - KNOWLEDGE-International Journal, 2022 - ikm.mk
KNOWLEDGE – International Journal Vol.55.4 RECOVERY OF POST COVID-19 SURVIVORS
WITH THE METHODS OF SANATORIAL AND SPA TRE Page 1 KNOWLEDGE – International …